Literature DB >> 28547180

Role of antioxidant treatment on DNA and lipid damage in the brain of rats subjected to a chemically induced chronic model of tyrosinemia type II.

Emilio L Streck1,2, Samira D T De Prá3,4, Paula Ronsani Ferro3,4, Milena Carvalho-Silva3,4, Lara M Gomes3,4, Jotele F Agostini5, Adriani Damiani6, Vanessa M Andrade6, Patrícia F Schuck5, Gustavo C Ferreira7, Giselli Scaini3,4.   

Abstract

Tyrosine levels are abnormally elevated in tissues and body fluids of patients with inborn errors of tyrosine metabolism. Tyrosinemia type II, which is caused by tyrosine aminotransferase deficiency, provokes eyes, skin, and central nervous system disturbances in affected patients. However, the mechanisms of brain damage are still poorly known. Considering that studies have demonstrated that oxidative stress may contribute, along with other mechanisms, to the neurological dysfunction characteristic of hypertyrosinemia, in the present study we investigated the effects of antioxidant treatment (NAC and DFX) on DNA damage and oxidative stress markers induced by chronic administration of L-tyrosine in cerebral cortex, hippocampus, and striatum of rats. The results showed elevated levels of DNA migration, and thus DNA damage, after chronic administration of L-tyrosine in all the analyzed brain areas, and that the antioxidant treatment was able to prevent DNA damage in cerebral cortex and hippocampus. However, the co-administration of NAC plus DFX did not prevent the DNA damage in the striatum. Moreover, we found a significant increase in thiobarbituric acid-reactive substances (TBA-RS) and DCFH oxidation in cerebral cortex, as well as an increase in nitrate/nitrite levels in the hippocampus and striatum. Additionally, the antioxidant treatment was able to prevent the increase in TBA-RS levels and in nitrate/nitrite levels, but not the DCFH oxidation. In conclusion, our findings suggest that reactive oxygen and nitrogen species and oxidative stress can play a role in DNA damage in this disorder. Moreover, NAC/DFX supplementation to tyrosinemia type II patients may represent a new therapeutic approach and a possible adjuvant to the current treatment of this disease.

Entities:  

Keywords:  Antioxidants; DNA damage; Inborn errors of metabolism; Oxidative stress; Tyrosinemia type II

Mesh:

Substances:

Year:  2017        PMID: 28547180     DOI: 10.1007/s11010-017-3070-5

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  52 in total

Review 1.  Is there a common molecular pathway for addiction?

Authors:  Eric J Nestler
Journal:  Nat Neurosci       Date:  2005-11       Impact factor: 24.884

2.  Tyrosine impairs enzymes of energy metabolism in cerebral cortex of rats.

Authors:  Rodrigo Binkowski de Andrade; Tanise Gemelli; Denise Bertin Rojas; Cláudia Funchal; Carlos Severo Dutra-Filho; Clovis Milton Duval Wannmacher
Journal:  Mol Cell Biochem       Date:  2012-02-05       Impact factor: 3.396

3.  N-acetylcysteine elicited increase in cytochrome c oxidase activity in mice synaptic mitochondria.

Authors:  M Martínez Banaclocha; N Martínez
Journal:  Brain Res       Date:  1999-09-18       Impact factor: 3.252

4.  Pharmacokinetics of systemically administered tyrosine: a comparison of serum, brain tissue and in vivo microdialysate levels in the rat.

Authors:  Rodolfo Bongiovanni; Bryan K Yamamoto; Catherine Simpson; George E Jaskiw
Journal:  J Neurochem       Date:  2003-10       Impact factor: 5.372

5.  An evaluation of the effects of acute and chronic L-tyrosine administration on BDNF levels and BDNF mRNA expression in the rat brain.

Authors:  Gabriela K Ferreira; Giselli Scaini; Isabela C Jeremias; Milena Carvalho-Silva; Cinara L Gonçalves; Talita C B Pereira; Giovanna M T Oliveira; Luiza W Kist; Maurício R Bogo; Patrícia F Schuck; Gustavo C Ferreira; Emilio L Streck
Journal:  Mol Neurobiol       Date:  2013-10-04       Impact factor: 5.590

6.  Effect of L-tyrosine in vitro and in vivo on energy metabolism parameters in brain and liver of young rats.

Authors:  Gabriela K Ferreira; Giselli Scaini; Milena Carvalho-Silva; Lara M Gomes; Lislaine S Borges; Júlia S Vieira; Larissa S Constantino; Gustavo C Ferreira; Patrícia F Schuck; Emilio L Streck
Journal:  Neurotox Res       Date:  2012-07-31       Impact factor: 3.911

7.  Regional tyrosine levels in rat brain after tyrosine administration.

Authors:  M C Morre; F Hefti; R J Wurtman
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575

8.  Creatine and pyruvate prevent the alterations caused by tyrosine on parameters of oxidative stress and enzyme activities of phosphoryltransfer network in cerebral cortex of Wistar rats.

Authors:  Rodrigo Binkowski de Andrade; Tanise Gemelli; Denise Bertin Rojas; Narielle Ferner Bonorino; Bruna May Lopes Costa; Cláudia Funchal; Carlos Severo Dutra-Filho; Clovis Milton Duval Wannmacher
Journal:  Mol Neurobiol       Date:  2014-06-25       Impact factor: 5.590

9.  Acute administration of l-tyrosine alters energetic metabolism of hippocampus and striatum of infant rats.

Authors:  Andrea C Ramos; Gabriela K Ferreira; Milena Carvalho-Silva; Camila B Furlanetto; Cinara L Gonçalves; Gustavo C Ferreira; Patrícia F Schuck; Emilio L Streck
Journal:  Int J Dev Neurosci       Date:  2013-04-16       Impact factor: 2.457

Review 10.  The comet assay for DNA damage and repair: principles, applications, and limitations.

Authors:  Andrew R Collins
Journal:  Mol Biotechnol       Date:  2004-03       Impact factor: 2.860

View more
  8 in total

1.  Evidence of hippocampal astrogliosis and antioxidant imbalance after L-tyrosine chronic administration in rats.

Authors:  Milena Carvalho-Silva; Lara M Gomes; Samira Dal-Toé de Prá; Leticia B Wessler; Patricia F Schuck; Giselli Scaini; Andreza Fabro de Bem; Carlos H Blum-Silva; Flávio H Reginatto; Jade de Oliveira; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2019-11-08       Impact factor: 3.584

2.  Omega-3 fatty acid supplementation can prevent changes in mitochondrial energy metabolism and oxidative stress caused by chronic administration of L-tyrosine in the brain of rats.

Authors:  Milena Carvalho-Silva; Lara M Gomes; Maria L Gomes; Bruna K Ferreira; Patricia F Schuck; Gustavo C Ferreira; Felipe Dal-Pizzol; Jade de Oliveira; Giselli Scaini; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2019-04-04       Impact factor: 3.584

3.  Tyrosine aminotransferase is involved in the oxidative stress response by metabolizing meta-tyrosine in Caenorhabditis elegans.

Authors:  Brett R Ipson; Rebecca A Green; John T Wilson; Jacob N Watson; Kym F Faull; Alfred L Fisher
Journal:  J Biol Chem       Date:  2019-05-01       Impact factor: 5.157

4.  Evaluation of dynamic thiol/disulfide homeostasis in hereditary tyrosinemia type 1 patients.

Authors:  Ayse Cigdem Aktuglu Zeybek; Ertugrul Kiykim; Salim Neselioglu; Halise Zeynep Iscan; Tanyel Zubarioglu; Mehmet Serif Cansever; Ozcan Erel
Journal:  Pediatr Res       Date:  2021-10-09       Impact factor: 3.953

5.  Antioxidants Reverse the Changes in the Cholinergic System Caused by L-Tyrosine Administration in Rats.

Authors:  Lara M Gomes; Giselli Scaini; Milena Carvalho-Silva; Maria L Gomes; Fernanda Malgarin; Luiza W Kist; Maurício R Bogo; Eduardo Pacheco Rico; Alexandra I Zugno; Pedro F P Deroza; Gislaine Z Réus; Airam B de Moura; João Quevedo; Gustavo C Ferreira; Patrícia F Schuck; Emilio L Streck
Journal:  Neurotox Res       Date:  2018-02-07       Impact factor: 3.911

6.  Effects of omega-3 fatty acids supplementation on inflammatory parameters after chronic administration of L-tyrosine.

Authors:  Rafaela Antonini; Giselli Scaini; Monique Michels; Mariane B D Matias; Patrícia F Schuck; Gustavo C Ferreira; Jade de Oliveira; Felipe Dal-Pizzol; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2019-12-11       Impact factor: 3.584

Review 7.  Experimental evidence of tyrosine neurotoxicity: focus on mitochondrial dysfunction.

Authors:  Jade de Oliveira; Hémelin Resende Farias; Emilio Luiz Streck
Journal:  Metab Brain Dis       Date:  2021-07-02       Impact factor: 3.584

8.  Towards resolving the enigma of the dichotomy of resveratrol: cis- and trans-resveratrol have opposite effects on TyrRS-regulated PARP1 activation.

Authors:  Megha Jhanji; Chintada Nageswara Rao; Mathew Sajish
Journal:  Geroscience       Date:  2020-11-27       Impact factor: 7.713

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.